ArticleUltrasonics sonochemistry2026
Cavitation behaviors of genetically engineered bacterial protein nanoparticles induced by pulsed ultrasound.
Article in Ultrasonics sonochemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Genetically engineered bacterial protein nanoparticles (GVs-E.coli) enhance the therapeutic efficacy of high-intensity focused ultrasound (HIFU) by virtue of their intrinsic tumor tropism, favorable biosafety profile, and inherent cavitation activity. However, the cavitation behavior of GVs-E.coli has not been systematically characterized, and the underlying regulatory mechanisms remain poorly elucidated presenting a critical knowledge gap that limits their optimal theranostic application. Herein, we investigated the cavitation behaviors of GVs-E.coli within a wall-free flow channel embedded in tissue-mimicking agarose phantoms using a customized ultrasound platform. Passive cavitation detection (PCD) was performed under varying peak negative pressures (PNPs) and bacterial concentrations, with acoustic emissions analyzed in both time and frequency domains. Our results revealed that the stable cavitation (SC) threshold of GVs-E.coli was 1.6 MPa and the inertial cavitation (IC) threshold was 2.2 MPa. Cavitation dose was positively correlated with PNP, yet harmonics and sub-harmonics exhibited distinct growth patterns.A critical concentration threshold of OD
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.